JOHNSON MEDICAL PRACTICE — All Prescriptions & Medications — Page 10
Practice Code: C82031 | LEICESTER, LE5 1BL
Showing results 451-500 of 656
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Other individually formulated bought in preparations | 30 | 1,525 | £2.0K | -8.2% ▼ |
| 30 | 51 | £315 | -16.1% ▼ | |
| 30 | 30 | £126 | -41.5% ▼ | |
| Enoxaparin | 29 | 766 | £2.5K | +41.5% ▲ |
| Desloratadine | 29 | 868 | £75 | +0.5% vs avg |
| Paliperidone | 29 | 29 | £7.5K | +90.7% ▲ |
| 29 | 1,120 | £1.6K | +127.7% ▲ | |
| Hyoscine hydrobromide | 28 | 1,008 | £163 | -18.0% ▼ |
| Tube feed 1 kcal/ml with fibre (0914011) | 28 | 493.5K | £7.7K | +171.3% ▲ |
| Tube feed 1.3kcal/ml with fibre, higher protein (0914011) | 28 | 313.0K | £5.5K | +170.4% ▲ |
| Zinc oxide | 28 | 5,585 | £181 | +39.2% ▲ |
| Hepatitis B | 28 | 28 | £317 | +164.6% ▲ |
| 28 | 284 | £782 | -41.4% ▼ | |
| Budesonide | 27 | 384 | £2.6K | +72.3% ▲ |
| Captopril | 27 | 2,664 | £2.4K | +86.5% ▲ |
| Safinamide | 27 | 810 | £1.8K | +34.0% ▲ |
| Acamprosate calcium | 27 | 2,996 | £335 | -22.5% ▼ |
| Dantrolene sodium | 27 | 1,692 | £273 | +49.7% ▲ |
| 27 | 1,316 | £917 | -27.3% ▼ | |
| 27 | 3,350 | £417 | +20.7% ▲ | |
| Co-magaldrox (Magnesium/aluminium hydroxide) | 26 | 14.0K | £80 | +220.9% ▲ |
| Propantheline bromide | 26 | 2,120 | £1.6K | +100.3% ▲ |
| Insulin glulisine | 26 | 270 | £1.5K | +21.3% ▲ |
| Tube feed 1 kcal/ml (0914021) | 26 | 644.3K | £12.1K | +235.9% ▲ |
| Acetylcysteine | 26 | 260 | £2.1K | +156.6% ▲ |
| 26 | 2,276 | £153 | -88.0% ▼ | |
| 26 | 630 | £4.1K | +103.5% ▲ | |
| Olmesartan medoxomil | 25 | 980 | £43 | -63.7% ▼ |
| Fluvastatin sodium | 25 | 1,400 | £181 | +8.1% ▲ |
| Cinnarizine | 25 | 2,876 | £132 | -46.6% ▼ |
| Desmopressin acetate | 25 | 2,344 | £1.9K | -52.1% ▼ |
| Triptorelin acetate | 25 | 25 | £1.7K | +74.4% ▲ |
| Diclofenac sodium | 25 | 1,168 | £135 | -50.8% ▼ |
| Salicylic acid | 25 | 222 | £68 | +97.7% ▲ |
| 25 | 100 | £81 | -19.7% ▼ | |
| 25 | 4,740 | £703 | -36.4% ▼ | |
| 25 | 1,340 | £4.6K | +2.6% ▲ | |
| 25 | 930 | £4.1K | +78.7% ▲ | |
| Amiloride hydrochloride | 24 | 672 | £333 | -4.6% ▼ |
| Dabigatran etexilate | 24 | 1,440 | £1.1K | -53.6% ▼ |
| Ins degludec/liraglutide | 24 | 99 | £3.2K | +49.3% ▲ |
| Acetazolamide | 24 | 3,444 | £134 | +10.8% ▲ |
| Sodium chloride | 24 | 84 | £1.1K | +262.6% ▲ |
| Light liquid paraffin | 24 | 9,000 | £143 | -29.5% ▼ |
| 24 | 1,080 | £1.5K | +145.3% ▲ | |
| Levomepromazine hydrochloride | 23 | 238 | £456 | -0.1% vs avg |
| Pramipexole | 23 | 1,110 | £224 | -76.6% ▼ |
| Pyridoxine hydrochloride | 23 | 1,120 | £449 | +7.0% ▲ |
| Ready to serve 4.5 - 5 kcal/ml energy (fat) liquid (0913142) | 23 | 65.4K | £2.2K | +105.1% ▲ |
| Ivermectin | 23 | 1,170 | £681 | +8.2% ▲ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.